Spark Biomedical -with CEO Daniel Powell and CSO Navid Khodaparast PhD

Spark Biomedical -with CEO Daniel Powell and CSO Navid Khodaparast PhD

Imagine a world where managing opioid withdrawal is less about suffering and more about relief. That's what Spark Biomedical's CEO Daniel Powell and CSO Navid Khodaparast PhD discuss in this eye-opening episode of 'The Recovering Reality Podcast'. Hosted by Erik Frederickson, this conversation dives into the innovative Sparrow Therapy System. This device delivers mild electrical signals through the skin around the ear, known as transcutaneous auricular neurostimulation (tAN™).

These signals trigger the brain to release endorphins, filling opioid receptors and easing withdrawal symptoms. The FDA-approved device can reduce symptoms within an hour and maintain relief for up to five days. It's also being explored for managing cravings, anxiety, depression, PTSD, and trauma. Tune in to discover how this groundbreaking technology could revolutionize addiction treatment.